Systemic absorption of oral cholestyramine

Area of Science:

• Gastroenterology
• Pathology
• Pharmacology

Background:

• Clostridium difficile toxin colitis is a serious intestinal infection.
• Cholestyramine is a medication used to treat conditions like diarrhea and high cholesterol.

Observation:

• A patient treated with oral cholestyramine for C. difficile colitis died from unrelated causes.
• Autopsy revealed resolved colitis but cholestyramine particles within the blood vessels of multiple organs.
• Cholestyramine particles were most concentrated in the ulcerated distal esophagus.

Findings:

• Cholestyramine particles disseminated systemically, reaching various tissues via the bloodstream.
• Bacteria were observed near cholestyramine particles, particularly in the esophagus.
• This suggests a potential common entry point for both cholestyramine and bacteria into circulation.

Implications:

• Oral cholestyramine administration may lead to unintended systemic particle dissemination.
• The findings raise questions about the safety and absorption of cholestyramine in patients with gastrointestinal compromise.
• Further research is needed to understand the clinical significance of systemic cholestyramine particle presence.